Department of Urology, Vanderbilt University Medical Center, Nashville, Tennessee.
J Urol. 2021 Oct;206(4):866-872. doi: 10.1097/JU.0000000000001871. Epub 2021 May 25.
Adrenocortical carcinoma is a rare but aggressive malignancy. While centralization of care to referral centers improves outcomes across common urological malignancies, there exists a paucity of data for low-incidence cancers. We sought to evaluate differences in practice patterns and overall survival in patients with adrenocortical carcinoma across types of treating facilities.
We identified all patients diagnosed with adrenocortical carcinoma from 2004-2016 in the National Cancer Database. The Kaplan-Meier method was used to evaluate overall survival and multivariable Cox regression analysis was used to investigate independent predictors of overall survival. The chi-square test was used to analyze differences in practice patterns.
We identified 2,886 patients with adrenocortical carcinoma. Median overall survival was 21.8 months (95% CI 19.8-23.8). Academic centers had improved overall survival versus community centers on unadjusted Kaplan-Meier analysis (p <0.05) and had higher rates of adrenalectomy or radical en bloc resection (p <0.001), performed more open surgery (p <0.001), administered more systemic therapy (p <0.001) and had lower rates of positive surgical margins (p=0.03). On multivariable analysis, controlling for treatment modality, academic centers were associated with significantly decreased risk of death (HR 0.779, 95% CI 0.631-0.963, p=0.021).
Treatment of adrenocortical carcinoma at an academic center is associated with improved overall survival compared to community programs. There are significant differences in practice patterns, including more aggressive surgical treatment at academic facilities, but the survival benefit persists on multivariable analysis controlling for treatment modality. Further studies are needed to identify the most important predictors of survival in this at-risk population.
肾上腺皮质癌是一种罕见但具有侵袭性的恶性肿瘤。虽然将护理集中到转诊中心可以提高常见泌尿外科恶性肿瘤的治疗效果,但针对低发癌症的相关数据仍然匮乏。我们旨在评估不同治疗机构的患者在肾上腺皮质癌治疗模式和总生存率方面的差异。
我们从国家癌症数据库中确定了 2004 年至 2016 年间所有被诊断为肾上腺皮质癌的患者。采用 Kaplan-Meier 法评估总生存率,采用多变量 Cox 回归分析探讨总生存率的独立预测因素。采用卡方检验分析治疗模式的差异。
我们共确定了 2886 例肾上腺皮质癌患者。中位总生存率为 21.8 个月(95%CI 19.8-23.8)。未校正 Kaplan-Meier 分析显示,与社区中心相比,学术中心的总生存率更高(p<0.05),且行肾上腺切除术或根治性整块切除术的比例更高(p<0.001),开放手术比例更高(p<0.001),接受系统治疗的比例更高(p<0.001),切缘阳性的比例更低(p=0.03)。多变量分析控制治疗方式后,学术中心与死亡风险显著降低相关(HR 0.779,95%CI 0.631-0.963,p=0.021)。
与社区项目相比,在学术中心治疗肾上腺皮质癌与总生存率提高相关。治疗模式存在显著差异,包括在学术机构进行更积极的手术治疗,但多变量分析控制治疗方式后,生存获益仍然存在。需要进一步研究来确定该高危人群生存的最重要预测因素。